Ph.D. in Biochemistry at Biocenter of University of Basel, Switzerland. My Ph.D. thesis opened the new field of novel molecular mechanisms of self-non-self-recognition based on glycan to glycan polyvalent interactions. I worked as a post-doctoral fellow at the University of Basel and as an associate professor at the University Hospital of Basel and Marine Biological Laboratory in Woods Hole, USA. During this period I have developed the novel technology for measurements of binding force and specificity between single pair of molecules in a physiological solution using atomic force microscopy. For this work published in Nature and Science as the senior author, I was awarded Marcel Merieux Prize. I have obtained 1st Class full professorship at the University of Rouen, France in Biochemistry and Molecular Biology and created my Gimmune GmbH company in Switzerland.. I have developed a novel immunological mechanism for the stimulation of NK human cell proliferation. I am currently occupying positions as the CEO of Gimmune GmbH located in Switzerland, as a university professor of immunology at Nanjing Medical University, and as the chief scientist at Libo in China.
Ph.D. in Biochemistry at Biocenter of University of Basel, Switzerland. My Ph.D. thesis opened the new field of novel molecular mechanisms of self-non-self-recognition based on glycan to glycan polyvalent interactions. I worked as a post-doctoral fellow at the University of Basel and as an associate professor at the University Hospital of Basel and Marine Biological Laboratory in Woods Hole, USA. During this period I have developed the novel technology for measurements of binding force and specificity between single pair of molecules in a physiological solution using atomic force microscopy. For this work published in Nature and Science as the senior author, I was awarded Marcel Merieux Prize. I have obtained 1st Class full professorship at the University of Rouen, France in Biochemistry and Molecular Biology and created my Gimmune GmbH company in Switzerland.. I have developed a novel immunological mechanism for the stimulation of NK human cell proliferation. I am currently occupying positions as the CEO of Gimmune GmbH located in Switzerland, as a university professor of immunology at Nanjing Medical University, and as the chief scientist at Libo in China.